• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Nameprosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented
Generic Nameprosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented
325 corporate drive
mahwah, NJ 07430
PMA NumberP000013
Supplement NumberS008
Date Received12/29/2006
Decision Date04/26/2007
Product Code
MRA[ Registered Establishments with MRA ]
Advisory Committee Orthopedic
Supplement Typereal-time process
Supplement Reason change design/components/specifications/material
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for a new locking mechanism design for the trident acetabular system (trident alumina inserts and trident acetabular shells), as well as associated revisions to the package insert. This design modification is intended to allow for ease of insertion of the alumina ceramic insert. The device, as modified, will be marketed under the trade name trident ii acetabular system (trident ii alumina inserts, trident ii acetabular shells) and is indicated for patients requiring primary or revision total hip arthroplasty due to non-inflammatory degenerative joint disease (osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, pelvic fracture, femoral fracture, failed fracture fixation, or diastrophic variant), or inflammatory joint disease.